MiNK Therapeutics, Inc.
(NASDAQ: INKT)
MiNK Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the discovery, development, and commercialization of allogeneic invariant natural killer T cell therapies to treat cancer and other immune mediated diseases. The company was founded in 2017 and is headquartered in New York, NY.
12.350
+1.420
(+12.99%)
Range
10.510 - 12.500
(18.93%)
Open
10.920
Previous Close
10.930
Bid Price
1.960
Bid Volume
8
Ask Price
1.970
Ask Volume
8
Volume
22,118
Value
-
Remark
Delayed prices. Updated at 05 Dec 2025 05:00.
Data powered by
View All Events
Loading Chart...
Please login to view stock data and analysis
